Prevention of nicotine addiction

Neuropsychopharmacological issues

Jack E. Henningfield, Nigel R. Jude

Research output: Contribution to journalArticle

Abstract

Most children and adolescents try smoking cigarettes; up to two-thirds discontinue. What explains the one-third or more who continue smoking? What physiological, pharmacological, and other environmental factors affect the risk of developing a pattern of chronic tobacco use? How can the transition from occasional use to chronic use be slowed, if not halted? What are the safest, most effective means of intervention for those children and adolescents who develop patterns of chronic daily cigarette smoking and would like to quit? How can they be motivated to want to quit? These are just a few of the issues that might be resolved in part by further neuropsychopharmacological research, but the challenges and barriers to conducting such research on children and adolescents are substantial. The barriers may be better understood by a brief summary of what neuropsychopharmacology research involves, and a corresponding summary of the disincentives to conduct such research.

Original languageEnglish (US)
JournalNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Volume1
Issue numberSUPPL. 1
StatePublished - 1999

Fingerprint

Nicotine
Smoking
Research
Tobacco Use
Motivation
Pharmacology

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Prevention of nicotine addiction : Neuropsychopharmacological issues. / Henningfield, Jack E.; Jude, Nigel R.

In: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, Vol. 1, No. SUPPL. 1, 1999.

Research output: Contribution to journalArticle

@article{097d13a024914252b2e84d9608bf77d1,
title = "Prevention of nicotine addiction: Neuropsychopharmacological issues",
abstract = "Most children and adolescents try smoking cigarettes; up to two-thirds discontinue. What explains the one-third or more who continue smoking? What physiological, pharmacological, and other environmental factors affect the risk of developing a pattern of chronic tobacco use? How can the transition from occasional use to chronic use be slowed, if not halted? What are the safest, most effective means of intervention for those children and adolescents who develop patterns of chronic daily cigarette smoking and would like to quit? How can they be motivated to want to quit? These are just a few of the issues that might be resolved in part by further neuropsychopharmacological research, but the challenges and barriers to conducting such research on children and adolescents are substantial. The barriers may be better understood by a brief summary of what neuropsychopharmacology research involves, and a corresponding summary of the disincentives to conduct such research.",
author = "Henningfield, {Jack E.} and Jude, {Nigel R.}",
year = "1999",
language = "English (US)",
volume = "1",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Prevention of nicotine addiction

T2 - Neuropsychopharmacological issues

AU - Henningfield, Jack E.

AU - Jude, Nigel R.

PY - 1999

Y1 - 1999

N2 - Most children and adolescents try smoking cigarettes; up to two-thirds discontinue. What explains the one-third or more who continue smoking? What physiological, pharmacological, and other environmental factors affect the risk of developing a pattern of chronic tobacco use? How can the transition from occasional use to chronic use be slowed, if not halted? What are the safest, most effective means of intervention for those children and adolescents who develop patterns of chronic daily cigarette smoking and would like to quit? How can they be motivated to want to quit? These are just a few of the issues that might be resolved in part by further neuropsychopharmacological research, but the challenges and barriers to conducting such research on children and adolescents are substantial. The barriers may be better understood by a brief summary of what neuropsychopharmacology research involves, and a corresponding summary of the disincentives to conduct such research.

AB - Most children and adolescents try smoking cigarettes; up to two-thirds discontinue. What explains the one-third or more who continue smoking? What physiological, pharmacological, and other environmental factors affect the risk of developing a pattern of chronic tobacco use? How can the transition from occasional use to chronic use be slowed, if not halted? What are the safest, most effective means of intervention for those children and adolescents who develop patterns of chronic daily cigarette smoking and would like to quit? How can they be motivated to want to quit? These are just a few of the issues that might be resolved in part by further neuropsychopharmacological research, but the challenges and barriers to conducting such research on children and adolescents are substantial. The barriers may be better understood by a brief summary of what neuropsychopharmacology research involves, and a corresponding summary of the disincentives to conduct such research.

UR - http://www.scopus.com/inward/record.url?scp=0033291074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033291074&partnerID=8YFLogxK

M3 - Article

VL - 1

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - SUPPL. 1

ER -